Literature DB >> 21258789

Insights into the mechanism of HIV-1 envelope induced membrane fusion as revealed by its inhibitory peptides.

Avraham Ashkenazi1, Yechiel Shai.   

Abstract

HIV-1 fusion with its target cells is mediated by the glycoprotein 41 (gp41) transmembrane subunit of the viral envelope glycoprotein (ENV). The current models propose that gp41 undergoes several conformational changes between the apposing viral and cell membranes to facilitate fusion. In this review we focus on the progress that has been made in revealing the dynamic role of the N-terminal heptad repeat (NHR) and the C-terminal heptad repeat (CHR) regions within gp41 to the fusion process. The involvement of these regions in the formation of the gp41 pre-hairpin and hairpin conformations during an ongoing fusion event was mainly discovered by their derived inhibitory peptides. For example, the core structure within the hairpin conformation in a dynamic fusion event is suggested to be larger than its high resolution structure and its minimal boundaries were determined in situ. Also, inhibitory peptides helped reveal the dual contribution of the NHR to the fusion process. Finally, we will also discuss several developments in peptide design that has led to a deeper understanding of the mechanism of viral membrane fusion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21258789     DOI: 10.1007/s00249-010-0666-z

Source DB:  PubMed          Journal:  Eur Biophys J        ISSN: 0175-7571            Impact factor:   1.733


  90 in total

1.  Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.

Authors:  D M Eckert; P S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

2.  How structure correlates to function for membrane associated HIV-1 gp41 constructs corresponding to the N-terminal half of the ectodomain.

Authors:  Kelly Sackett; Yechiel Shai
Journal:  J Mol Biol       Date:  2003-10-10       Impact factor: 5.469

3.  Ultrashort antibacterial and antifungal lipopeptides.

Authors:  Arik Makovitzki; Dorit Avrahami; Yechiel Shai
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-12       Impact factor: 11.205

Review 4.  HIV entry and its inhibition.

Authors:  D C Chan; P S Kim
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

5.  A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding.

Authors:  C D Rizzuto; R Wyatt; N Hernández-Ramos; Y Sun; P D Kwong; W A Hendrickson; J Sodroski
Journal:  Science       Date:  1998-06-19       Impact factor: 47.728

6.  Conjugation of a magainin analogue with lipophilic acids controls hydrophobicity, solution assembly, and cell selectivity.

Authors:  Dorit Avrahami; Yechiel Shai
Journal:  Biochemistry       Date:  2002-02-19       Impact factor: 3.162

7.  Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface.

Authors:  Rob J Center; Richard D Leapman; Jacob Lebowitz; Larry O Arthur; Patricia L Earl; Bernard Moss
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

8.  A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition.

Authors:  C Wild; T Oas; C McDanal; D Bolognesi; T Matthews
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

9.  Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for fusion and leakage.

Authors:  J L Nieva; S Nir; A Muga; F M Goñi; J Wilschut
Journal:  Biochemistry       Date:  1994-03-22       Impact factor: 3.162

10.  Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion.

Authors:  G B Melikyan; R M Markosyan; H Hemmati; M K Delmedico; D M Lambert; F S Cohen
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

View more
  18 in total

1.  Structural basis of potent and broad HIV-1 fusion inhibitor CP32M.

Authors:  Xue Yao; Huihui Chong; Chao Zhang; Zonglin Qiu; Bo Qin; Ruiyun Han; Sandro Waltersperger; Meitian Wang; Yuxian He; Sheng Cui
Journal:  J Biol Chem       Date:  2012-06-07       Impact factor: 5.157

2.  Viral envelope protein folding and membrane hemifusion are enhanced by the conserved loop region of HIV-1 gp41.

Authors:  Avraham Ashkenazi; Mathias Viard; Yael Wexler-Cohen; Robert Blumenthal; Yechiel Shai
Journal:  FASEB J       Date:  2011-03-23       Impact factor: 5.191

3.  A GxxxG-like motif within HIV-1 fusion peptide is critical to its immunosuppressant activity, structure, and interaction with the transmembrane domain of the T-cell receptor.

Authors:  Omri Faingold; Tomer Cohen; Yechiel Shai
Journal:  J Biol Chem       Date:  2012-08-07       Impact factor: 5.157

4.  Recombinant expression, purification, and biophysical characterization of the transmembrane and membrane proximal domains of HIV-1 gp41.

Authors:  Zhen Gong; Sarah A Kessans; Lusheng Song; Katerina Dörner; Ho-Hsien Lee; Lydia R Meador; Joshua LaBaer; Brenda G Hogue; Tsafrir S Mor; Petra Fromme
Journal:  Protein Sci       Date:  2014-09-03       Impact factor: 6.725

5.  Dissociation of the trimeric gp41 ectodomain at the lipid-water interface suggests an active role in HIV-1 Env-mediated membrane fusion.

Authors:  Julien Roche; John M Louis; Alexander Grishaev; Jinfa Ying; Adriaan Bax
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

6.  Structure of an HIV-1-neutralizing antibody target, the lipid-bound gp41 envelope membrane proximal region trimer.

Authors:  Patrick N Reardon; Harvey Sage; S Moses Dennison; Jeffrey W Martin; Bruce R Donald; S Munir Alam; Barton F Haynes; Leonard D Spicer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

7.  Customizable de novo design strategies for DOCK: Application to HIVgp41 and other therapeutic targets.

Authors:  William J Allen; Brian C Fochtman; Trent E Balius; Robert C Rizzo
Journal:  J Comput Chem       Date:  2017-09-22       Impact factor: 3.376

8.  Structure-based identification of inhibitors targeting obstruction of the HIVgp41 N-heptad repeat trimer.

Authors:  T Dwight McGee; Hyun Ah Yi; William J Allen; Amy Jacobs; Robert C Rizzo
Journal:  Bioorg Med Chem Lett       Date:  2017-05-08       Impact factor: 2.823

9.  HIV-1 gp41 transmembrane domain interacts with the fusion peptide: implication in lipid mixing and inhibition of virus-cell fusion.

Authors:  Eliran Moshe Reuven; Yakir Dadon; Mathias Viard; Nurit Manukovsky; Robert Blumenthal; Yechiel Shai
Journal:  Biochemistry       Date:  2012-03-23       Impact factor: 3.162

10.  The Type VI secretion system spike protein VgrG5 mediates membrane fusion during intercellular spread by pseudomallei group Burkholderia species.

Authors:  Isabelle J Toesca; Christopher T French; Jeff F Miller
Journal:  Infect Immun       Date:  2014-01-13       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.